Skip to main content
SpringerLink
Log in
Book cover

Arzneiverordnungs-Report 2013 pp 521–585Cite as

Dermatika

  • Chapter

  • 1747 Accesses

Zusammenfassung

Dermatika zählen in Deutschland zu den verordnungsstärksten Arzneimitteln. Ihre Anwendungsgebiete sind sehr unterschiedlich. Entsprechend heterogen sind die Stoffklassen, die von den Corticosteroidexterna über die Antimykotika – sofern präferenziell zur Behandlung von Haut- und Nagelmykosen zugelassen – sowie die Wundbehandlungsmittel bis zu den Hautschutz- und Pflegemitteln reichen (Abbildung 22.1). Antimykotika mit anderen Indikationen finden sich in Kapitel 9 (Antibiotika und Chemotherapeutika), Kapitel 26 (Gynäkologika) und Kapitel 34 (Mund- und Rachentherapeutika).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ågren MS, Ostenfeld U, Kallehave F, Gong Y, Raffn K, Crawford ME, Kiss K, Friis-Møller A, Gluud C, Jorgensen LN (2006): A randomized, double-blind, placebo-controlled multicenter trial evaluating topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Repair Regen 4: 526–535.

    Article  Google Scholar 

  • Alsterholm M, Flytström I, Bergbrant IM, Faergemann J (2010): Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 90: 52–57.

    Article  PubMed  Google Scholar 

  • Alston SJ, Cohen BA, Braun M (2003): Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics 111: 201–203.

    Article  PubMed  Google Scholar 

  • Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P et al. (1994): Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30: 977–981.

    Article  PubMed  CAS  Google Scholar 

  • Ammon HPT, Sabieraj J, Kaul R (1996): Kamille. Mechanismus der antiphlogistischen Wirkung von Kamillenextrakten und -inhaltsstoffen. Dtsch Apoth Ztg 136: 1821–1834.

    Google Scholar 

  • Anonymus (2002): New treatments for actinic keratoses. Medical Letter 44: 57–58.

    Google Scholar 

  • Antille C, Saurat JH, Lübbe J (2004): Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 140: 457–460.

    Article  PubMed  Google Scholar 

  • Arican O, Sasmaz S, Ozbulu O (2006): Increased suicidal tendency in a case of psoriasis vulgaris under acitretin treatment. J Eur Acad Dermatol Venerol 20: 464–465.

    Article  CAS  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (1999): Nutzen und Risiken durch Fumarsäure-Ester bei der Therapie der Psoriasis. Dtsch Ärztebl 96: A-721.

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2005): Myopathie nach Tacrolimus- Salbe (Protopic®). Dtsch Ärztebl 102: A3138.

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2006): Psychiatrische Reaktionen nach Terninafin (Lamisil®). Dtsch Ärztebl 103: A3432.

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2011): Multiple aktinische Keratosen (Carcinomata in situ der Haut) nach langjähriger topischer Anwendung von Tacrolimus (Protopic®). Dtsch Ärztebl 108: A545-A546.

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2013a): Rhabdomyolyse nach Isotretinoin. Dtsch Ärztebl 110: A 240.

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2013b): Nokardiose bei Lymphopenie durch Fumaderm® (Aus der UAW-Datenbank). Dtsch Ärztebl 110: A 1220?1221.

    Google Scholar 

  • Aziz Z, Abu SF, Chong NJ (2012): A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns 38: 307–318.

    Article  PubMed  CAS  Google Scholar 

  • Baran R, Kaoukhov A (2005): Topical antifungal drugs fort he treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venerol 19: 21–29.

    Article  CAS  Google Scholar 

  • Barker JNWN (2011): Methotrexate or fumarates: which is the best oral treatment for psoriasis? Br J Dermatol 164: 695.

    Article  PubMed  CAS  Google Scholar 

  • Bell-Syer SEM, Hart R, Crawford F, Torgerson DJ, Tyrell W, Russell I (2006): Oral treatments for fungal infections of the skin of the foot (Cochrane Review). In: The Cochrane Library, Issue 1 2006. Oxford: Update Software.

    Google Scholar 

  • Berrios RL, Arbiser JL (2011): Effectiveness of gentian violet and similar products commonly used to treat pyodermas. Dermatol Clin 29: 69–73.

    Article  PubMed  CAS  Google Scholar 

  • Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA,; Multinational Study Group (2003): Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double-blind, parallel group study. Brit Med J 326: 1367–1373.

    Google Scholar 

  • Bewley A for the Dermatology Working Group (2008): Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 158: 917–920.

    Google Scholar 

  • Biogen Idec GmbH (2013): Wichtige Hinweise an medizinische Fachkreise: Fumaderm® initial/Fumaderm® - Vermeidung des Risikos opportunistischer Infektionen durch Einhaltung regelmäßiger Laborkontrollen und weiterer Warnhinweise während der Therapie. Internet: www.akdae.de/Arzneimittelsicherheit/RHB/20130625.pdf

  • Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke W-H (2003): Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis 49: 80–84.

    Article  PubMed  CAS  Google Scholar 

  • Boguniewicz M, Leung DY (2010): Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125: 4–13.

    Article  PubMed  Google Scholar 

  • Booij MT, van De Kerkhof PC (2011): Acitretin revisited in the era of biologics. J Dermatolog Treat 22: 86–89.

    Article  PubMed  CAS  Google Scholar 

  • Bradley M, Cullum N, Sheldon T (1999): The debridement of chronic wounds: a systematic review. Health Technol Assess 3: 1–78.

    PubMed  CAS  Google Scholar 

  • Braun R (Hrsg.) (2012): Arzneistoff-Profile, Basisinformation über arzneilich wirksame Wirkstoffe. Stammlieferung 1982 mit 1. bis 26. Erg.-Lieferung 2012, Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn.

    Google Scholar 

  • Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC, Landthaler M (2005): Dermatologie und Venerologie, 5. Auflage. Springer Medizin Verlag, Heidelberg.

    Book  Google Scholar 

  • Bristow IR, Baran R (2006): Topical and oral combination therapy for toenail onychomycosis. An updated review. J Am Podiatr Med Associat 96: 116–119.

    Google Scholar 

  • Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H (2009): Contact dermatitis due to use of Octenisept(R) in wound care. J Dtsch Dermatol Ges 7: 759–765.

    PubMed  Google Scholar 

  • Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K (2003): Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Manag Care 12: 47–54.

    PubMed  Google Scholar 

  • Chen SL, Yan J, Wang FS (2010): Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials. J Dermatolog Treat 21: 144–156.

    Article  PubMed  CAS  Google Scholar 

  • Christiansen B (1988): Untersuchungen über die Wirksamkeit eines Hautdesinfektionsmittels mit kationenaktivem Zusatz. Zbl Bakt Hyg B 186: 368–374.

    CAS  Google Scholar 

  • Chroni E, Monastirli A, Tsambaos D (2010): Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf 33: 25–34.

    Article  PubMed  CAS  Google Scholar 

  • Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR (2007): Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol 6: 495–498.

    PubMed  Google Scholar 

  • Crawford F, Young P, Godfrey C, Bell-Syer SEM, Hart R, Brunt E, Russel I (2002): Oral treatments for toenail onychomycosis. Arch Dermatol 138: 811–816.

    Article  PubMed  CAS  Google Scholar 

  • Crawford F, Hollis S (2007): Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2007 Jul 18 (3): CD001434.

    Google Scholar 

  • Dall’oglio F, D’Amico V, Nasca MR, Micali G (2012): Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol 13: 73–96.

    Article  PubMed  Google Scholar 

  • Darkes MJM, Scott LJ, Goa KL (2003): Terbinafine. A review of its use in onychomycosis in adults. Am J Clin Dermatol 4: 39–65.

    Article  PubMed  Google Scholar 

  • Del Rosso JQ, Pillai R, Moore R (2010): Absence of degradation of tretinoin when benzoyl peroxide is combined with an optimized formulation of tretinoin gel (0.05%). J Clin Aesthet Dermatol 3: 26–28.

    Google Scholar 

  • Deutsche Dermatologische Gesellschaft (2009a): Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer Index. AWMF-Leitlinien-Register Nr. 013/034, www.awmf.org/uploads/tx_szleitlinien/013-034.pdf.

  • Deutsche Dermatologische Gesellschaft (2009b): Psoriasis des behaarten Kopfes. AWMF-Leitlinien-Register Nr. 013/074, www.awmf.org/uploads/tx_szleitlinien/013-074.pdf.

  • Deutsche Dermatologische Gesellschaft (2011a): Leitlinie zur Therapie der Psoriasis vulgaris - Update 2011. AWMF-Leitlinien-Register Nr. 013/001, www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Psoriasis_vulgaris_Therapie_01.pdf.

  • Deutsche Dermatologische Gesellschaft (2011b): Behandlung der Akne. AWMF-Leitlinien-Register Nr. 013/017, www.awmf.org/uploads/tx_szleitlinien/013-017l_S2k_Behandlung_der_Akne_2011-10-Korrektur.pdf.

  • Deutsche Dermatologische Gesellschaft (2011c): Leitlinie zur Behandlung der aktinischen Keratosen C44.X. AWMF-Leitlinien-Register Nr. 013/041, www.awmf.org/uploads/tx_szleitlinien/013-041l_S1_Aktinische_Keratose_2012-01.pdf.

  • Deutsche Dermatologische Gesellschaft, Deutsche Gesellschaft für Allergologie und klinische Immunologie e.V., Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V. u.a. (2008): Neurodermitis. AWMF-Leitlinien-Register Nr. 013/027, www.awmf.org/uploads/tx_szleitlinien/013-027l_S2e_Neurodermitis_01.pdf.

  • Deutsche Dermatologische Gesellschaft und Berufsverband Deutscher Dermatologen (2009): Therapie des atopischen Ekzems mit Calcimeurin-Inhibitoren. AWMFLeitlinien- Register Nr. 013/037, www.awmf.org/uploads/tx_szleitlinien/013-037.pdf.

  • Deutsche Dermatologische Gesellschaft und Deutschsprachige Mykologische Gesellschaft (2008): Tinea der freien Haut. AWMF-Leitlinien-Register Nr. 013-002, www.awmf.org/uploads/tx_szleitlinien/013-002.pdf.

  • Deutsche Dermatologische Gesellschaft, Österreichische Gesellschaft für Dermatologie und Venerologie, Arbeitskreis Pharmaökonomie in der Dermatologie et al. (2008): Neurodermitis, AWMF-Leitlinien-Register Nr. 013/027, www.awmf.org/uploads/tx_szleitlinien/013-027l_S2e_Neurodermitis_01.pdf.

  • Deutsche Gesellschaft für Phlebologie (2008): Diagnostik und Therapie des Ulcus cruris venosum. AWMF-Leitlinien-Register Nr. 037/009, www.awmf.org/uploads/tx_szleitlinien/037-009_S3_Diagnostik_und_Therapie_des_Ulcus_cruris_venosum_lang_08-2008_08-2013.pdf.

  • Dobie D, Gray J (2004): Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 89: 74–77.

    Article  PubMed  CAS  Google Scholar 

  • Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Webster SB, Whitaker DC, Butler B, Lowery BJ, Raimer SA, Krafchik BR, Olsen E, Weston WL (1996): Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol 35: 615–619.

    Article  PubMed  CAS  Google Scholar 

  • Drucker CR (2012): Update on topical antibiotics in dermatology. Dermatol Ther 25: 6–11.

    Article  PubMed  Google Scholar 

  • Ebner F, Heller A, Rippke F, Tausch I (2002): Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol 3: 427–433.

    Article  PubMed  Google Scholar 

  • Eckhard M, Lengler A, Liersch J, Bretzel RG, Mayser P (2007): Fungal foot infections in patients with diabetes mellitus - results of two independent investigations. Mycoses 50 (Suppl 2): 14–19.

    Article  PubMed  Google Scholar 

  • Eifler-Bollen R, Fluhr JW (2005): Antimikrobiell wirksame Magistralrezepturen. Stellenwert in der Praxis und kritische Anmerkungen. Hautarzt 56: 752–758.

    Article  PubMed  CAS  Google Scholar 

  • El Sayed F, Ammoury A, Dhaybi R, Bazex J (2006): Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol 54: 548–550.

    Article  Google Scholar 

  • Ermis U, Weis J, Schulz JB (2013): PML in a patient treated with fumaric acid. N Engl J Med 368:1657–1658.

    Article  PubMed  CAS  Google Scholar 

  • Erbagci Z (2004): Topical therapy for dermatophytoses. Should corticosteroids be included? Am J Clin Dermatol 5: 375–384.

    Article  PubMed  Google Scholar 

  • European Medicines Agency (EMA) (2006): European Medicines Agency recommends cautious use of Protopic/Protopy and Elidel. www.emea.europa.eu/pdfs/general/direct/pr/9888206en.pdf

  • Fallah Arani S, Neumann H, Hop WC, Thio HB (2011): Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial. Br J Dermatol 164:855–861.

    Article  CAS  Google Scholar 

  • Fallen RS, Gooderham M (02012): Rosacea: update on management and emerging therapies. Skin Therapy Lett 17:1–4.

    Google Scholar 

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2010): Topical calcineurin inhibitors: Literature review. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255139.pdf.

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2011): Topical calcineurin inhibitors: Literature review addendum. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisory-Committee/UCM255140.pdf.

  • Ference JD, Last AR (2009): Choosing topical corticosteroids. Am Fam Physician 79: 135–140.

    PubMed  Google Scholar 

  • Fleischer AB jr, Abramovits W, Breneman D, Jaracz E; US/Canada tacrolimus ointment study group (2007): Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatol Treat 18: 151–157.

    Google Scholar 

  • Fleischer AB, Feldman SR (1999): Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Clin Ther 10: 1725–1731.

    Article  Google Scholar 

  • Fluhr JW, Cavallotti C, Berardesca E (2008): Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol 26: 380–386.

    Article  PubMed  Google Scholar 

  • Fluhr JW, Degitz K (2010): Antibiotika, Azelainsäure und Benzoylperoxid in der topische Aknetherapie. J Dtsch Dermatol Ges 8 (Suppl 1): S24–30.

    PubMed  Google Scholar 

  • Fölster-Holst R, Latussek E (2007): Synthetic tannins in dermatology--a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol 24: 296–301.

    Article  PubMed  Google Scholar 

  • Food and Drug Adminstration (2005): Elidel (pimecrolimus) Cream and Protopic (tacrolimus) Ointment. www.fda.gov/cder/drug/advisory/elidel_protopic.htm.

  • Frankel HC, Qureshi AA (2012): Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Am J Clin Dermatol 13: 113–123.

    Article  PubMed  Google Scholar 

  • Friese K, Neumann G, Siebert J (2003): Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis. Arch Gynecol Obstet 268: 194–197.

    Article  PubMed  CAS  Google Scholar 

  • Fuchslochner M, Rzany B (2002): Orale anticholinerge Therapie der fokalen Hyperhidrose mit Methantheliniumbromid (Vagantin®). Hautarzt 53: 151–152.

    Article  Google Scholar 

  • Garnock-Jones KP, Perry CM (2009):Alitretinoin: in severe chronic hand eczema. Drugs 69:1625–1634.

    Article  PubMed  CAS  Google Scholar 

  • Gaspari A, Tyring SK, Rosen T (2009): Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 8: 467–474.

    Google Scholar 

  • Gemeinsamer Bundesausschuss (2013): Richtlinie des Gemeinsamen Bundesausschusses über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel- Richtlinie/AM-RL) in der Fassung vom 18. Dezember 2008/22. Januar 2009, veröffentlicht im Bundesanzeiger 2009, Nr. 49a, zuletzt geändert am 17. Januar 2013, veröffentlicht BAnz AT 05.04.2013 B in Kraft getreten am 6. April 2013, www.gba.de/downloads/62-492-699/AM-RL_2013-01-17_2013-04-06.pdf.

  • Gibbs S, Harvey I (2006): Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001781. DOI: 10.1002/14651858. CD001781.pub2.

    Google Scholar 

  • Glenn CJ, Kobraei KB, Russo JJ (2011): New-onset psoriasis associated with adalimumab: a report of two cases. Dermatol Online J 17: 15.

    PubMed  Google Scholar 

  • Gloor M (1982): Pharmakologie dermatologischer Externa. Springer-Verlag, Berlin Heidelberg New York.

    Book  Google Scholar 

  • Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, Ziegler J (2002): Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 205: 46–53.

    Article  PubMed  CAS  Google Scholar 

  • González U, Seaton T, Bergus G, Jacobson J, Martínez-Monzón C.(2007): Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007, Issue 4. Art. No.: CD004685. DOI: 10.1002/14651858.CD004685.pub2.

    Google Scholar 

  • Gorman CR, White SW (2005): Rosaceiform dermatitis as a complication of treatment of facial seborrhoic dermattis with 1% pimecrolimus cream. Arch Dermatol 141: 1168.

    Article  PubMed  Google Scholar 

  • Griffiths CE, Barker JN (2007): Pathogenesis and clinical features of psoriasis. Lancet 370: 263–271.

    Article  PubMed  CAS  Google Scholar 

  • Grover C, Arora P, Manchanda V (2012): Comparative evaluation of griseofulvin, terbinafine und fluconazole in the trteatment of tinea capitis. Int J Dermatol 51: 455–458.

    Article  PubMed  CAS  Google Scholar 

  • Grover C, Khurana A (2012): An update on treatment of onychomycosis. Mycoses 55:541–551.

    Article  PubMed  Google Scholar 

  • Gupta AK (2002): Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. J Am Pediatr Med Assoc 92: 272–286.

    Google Scholar 

  • Gupta AK, Cherman AM, Tyring SK (2005): Viral and nonviral uses of imiquimod: A review. J Cut Med Surg 8: 338–352.

    Google Scholar 

  • Gupta AK, Cooper EA (2008): Update in antifungal therapy of dermatophytosis. Mykopathologia 166: 353–367.

    Article  Google Scholar 

  • Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM (2004): Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 5: 225–237.

    Article  PubMed  Google Scholar 

  • , Hahn C Röseler S, Fritzsche R, Schneider R, Merk HF (1993): Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 28: 81–83.

    Article  PubMed  CAS  Google Scholar 

  • Haugh M, Helou S, Boissel JP, Cribier BJ (2002): Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials. Br J Dermatol 147: 118–121.

    Article  PubMed  CAS  Google Scholar 

  • Hauschild A, Kähler KC, Egberts F (2006): Moderne Behandlungsoptionen bei aktinischen Keratosen der Haut. Dtsch Med Wochenschr 131: 447–452.

    Article  PubMed  CAS  Google Scholar 

  • Heikkinen AK, Susitaival P (2011): Severe systemic reaction to topical imiquimod. Acta Derm Venereol 91: 594–595.

    PubMed  CAS  Google Scholar 

  • Hengge UR, Ruzicka T, Schartz RA, Cork MJ (2006): Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54: 1–15.

    Article  PubMed  Google Scholar 

  • Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN (2003): Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 149: 363–369.

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann R, Happle R (2000): Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. Eur J Dermatol 10: 410–417.

    PubMed  CAS  Google Scholar 

  • Hornstein OP, Nürnberg E (Hrsg) (1985): Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Georg Thieme Verlag, Stuttgart New York.

    Google Scholar 

  • Hund M, Sinkgraven R, Rzany B (2004) Randomisierte, plazebokontrollierte klinische Doppelblindstudie zur Wirksamkeit und Verträglichkeit der oralen Therapie mit Methantheliniumbromid (Vagantin®) bei fokaler Hyperhidrose. J Dtsch Dermatol Ges 2: 43–349.

    Google Scholar 

  • Iorizzo M, Piraccini BM, Tosti A (2010): Today’s treatments options for onychomycosis. J Dtsch Dermatol Ges 8: 875–879.

    PubMed  Google Scholar 

  • Jarvis B, Figgitt DP (2003): Topical 3% diclofenac in 2.5% hyaluronic acid gel. A review of its use in patients with actinic keratoses. Am J Clin Dermatol 4: 203–213.

    Article  PubMed  Google Scholar 

  • Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB (1999): Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 5: 2006–2011.

    PubMed  CAS  Google Scholar 

  • Kakourou T, Uksal U; European Society for Pediatric Dermatology (2010): Guidelines for the management of tinea capitis in children. Pediatr Dermatol 27: 226–228.

    Google Scholar 

  • Kalavala M, Dohil MA (2011): Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. Am J Clin Dermatol 12: 15–24.

    Article  PubMed  Google Scholar 

  • Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W (2011): Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts. Sex Transm Dis 38: 216–218.

    Article  PubMed  CAS  Google Scholar 

  • Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, Berger M, van der Wouden JC. Interventions for impetigo. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD003261. DOI: 10.1002/14651858.CD003261.pub3.

    Google Scholar 

  • Koo JYM (2005): New developments in topical sequential therapy for psoriasis. Skin Therapy Lett 10: 1–4.

    PubMed  CAS  Google Scholar 

  • Korting HC (1995): Dermatotherapie: ein Leitfaden. Springer-Verlag, Berlin Heidelberg New York.

    Book  Google Scholar 

  • Korting HC, Schäfer-Korting M, Klövekorn W, Klövekorn G, Martin C, Laux P (1995): Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 48: 461–465.

    Article  PubMed  CAS  Google Scholar 

  • Krug M, Oji V, Traupe H, Berneburg M (2009): Ichthyoses - Part 1: Differential diagnosis of vulgar ichthyoses and therapeutic options. J Dtsch Dermatol Ges 7: 511–519.

    PubMed  Google Scholar 

  • Küster W, Bohnsack K, Rippke F, Upmeyer HJ, Groll S, Traupe H (1998): Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 196: 217–222.

    Article  PubMed  Google Scholar 

  • Küster W (2006): Ichthyosen: Vorschläge für eine verbesserte Therapie. Dtsch Ärztebl 103: A1684-A1689.

    Google Scholar 

  • Kujath P, Michelsen A (2008): Wunden - von der Physiologie zum Verband. Dtsch Ärztebl 105: 239–248.

    Google Scholar 

  • Kwok CS, Gibbs S, Bennen C, Holland R, Abbott R (2012): Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews 2012, Issue 9, Art, No.: CD00178L DOr: 10,1002/14651858,CD00178Lpub3,

    Google Scholar 

  • Lakshmi C, Srinivas CR (2012): Hand eczema: An update. Indian J Dermatol Venereol Leprol 78: 569–582.

    Article  PubMed  Google Scholar 

  • Langer A, Rogowski W (2009): Systematic review of economic evaluations of human cellderived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research 2009, 9: 115 (doi:10.1186/1472-6963-9-115)

    Google Scholar 

  • Langner A, Sheehan-Dare R, Layton A (2007): A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol 21: 311–319.

    Article  PubMed  CAS  Google Scholar 

  • Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Ågren MS (2007): Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 15: 2–16.

    Article  PubMed  Google Scholar 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R (2005): Treatment options - development of consensus guidelines. J Eur Acad Dermatol Venereol 19 (suppl 1): 25–33.

    Article  PubMed  Google Scholar 

  • Lee S, Selva D, Huilgol SC, Goldberg RA, Leibovitch I (2007): Pharmacological treatments for basal cell carcinoma. Drugs 67: 915–934.

    Article  PubMed  CAS  Google Scholar 

  • Lohde H, Stahlmann R (Hrsg.) (2004): Nadifloxacin - irrationaler Einsatz eines Fluorchinolons zur lokalen Aknetherapie. Zeitschr Chemother 25: 27–29.

    Google Scholar 

  • Løkkevik E, Skovlund E, Reitan JB, Hannisdal E, Tanum G (1996): Skin treatment with Bepanthen cream versus no cream during radiotherapy. Acta Oncol 35: 1021–1026.

    Article  PubMed  Google Scholar 

  • Lynde C, Cambazard F, Ruzicka T, Sebastian M, Brown TC, Maares J (2011): Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment. Clin Exp Dermatol 37: 712–717.

    Article  Google Scholar 

  • Magin P, Sullivan J (2010): Suicide attempts in people taking isotretinoin for acne. Br Med J 341: c5866.

    Article  Google Scholar 

  • Maiche AG, Gröhn P, Mäki-Hokkonen H (1991): Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30: 395–396.

    Article  PubMed  CAS  Google Scholar 

  • Mason J, Mason AR, Cork MJ (2002): Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 146: 351–364.

    Article  PubMed  CAS  Google Scholar 

  • Mayser P, Freund V, Budihardja D (2009): Toenail onychomycosis in diabetic patients: issues and managemant. Am J Clin Dermatol 10: 211–220.

    Article  PubMed  Google Scholar 

  • McClellan KJ, Noble S (2000): Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1: 191–199.

    Article  PubMed  CAS  Google Scholar 

  • McIntyre WJ, Downs MR, Bedwell SA (2007): Treatment options for actinic keratoses. Am Fam Physician 76: 667–671.

    PubMed  Google Scholar 

  • Menezes de Padua CA, Schnuch A, Nink K, Pfahlberg A, Uter W (2008): Allergic contact dermatitis to topical drugs - epidemiological risk assessment. Pharmacoepidemiol Drug Saf 17:813–821.

    Article  Google Scholar 

  • Merk HF (2007): Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 46: 12–18.

    Article  PubMed  CAS  Google Scholar 

  • Möhrenschlager M, Seidl HP, Ring J, Abeck D (2005): Pediatric tinea capitis. Recognition and management. Am J Clin Dermatol 6: 203–213.

    Article  PubMed  Google Scholar 

  • Moore AY (2009): Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat 20: 328–335.

    Article  PubMed  Google Scholar 

  • Moore ZEH, Cowman S (2013): Wound cleansing for pressure ulcers. Cochrane Database Syst Rev. 2013, Issue 3: CD004983. doi: 10.1002/14651858.CD004983.pub3.

    Google Scholar 

  • Mosti G (2013): Wound care in venous ulcers. Phlebology 28 (Suppl 1): 79–85.

    Article  PubMed  Google Scholar 

  • Müller G, Kramer A (2008) Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Antimicrob Chemother 61: 1281–1287.

    Article  CAS  Google Scholar 

  • Muller A, Talon D, Potier A, Belle E, Cappelier G, Bertrand X (2005): Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Critical Care 9: R246–R250.

    Article  PubMed  Google Scholar 

  • Naldi L, Griffiths CEM (2005): Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 152: 597–615.

    Article  PubMed  CAS  Google Scholar 

  • Niedner R (1998): Kortikoide in der Dermatologie. UNI-MED Verlag, Bremen.

    Google Scholar 

  • Niedner R, Ziegenmeyer J (Hrsg) (1992): Dermatika. Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftliche Verlagsgesellschaft, Stuttgart.

    Google Scholar 

  • Opstelten W, Neven AK, Eekhof J (2008): Treatment and prevention of herpes labialis. Can Fam Physician 54: 1683–1687.

    PubMed  Google Scholar 

  • Palfreyman S, Nelson EA, Michaels JA (2007): Dressings for venous leg ulcers: systematic review and mety-analysis. Br Med J 335: 244–248.

    Article  Google Scholar 

  • Paller AS, Lebwohl M, Fleischer AB jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group (2005): Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 52: 810–822.

    Google Scholar 

  • Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ, for the Psoriasis Foundation (2007): National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143: 239–242.

    Google Scholar 

  • Patel B, Siskin S, Krazmien R, Lebwohl M (1998): Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 38: 1010–1011.

    Article  PubMed  CAS  Google Scholar 

  • Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B (2009): European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23 (Suppl 2): 1–70.

    Article  PubMed  Google Scholar 

  • Peserico A, Städtler G, Sebastian M, Fernandez RS, Vick K, Bieber T (2008): Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double- blind, controlled study. Br J Dermatol 158: 801–807.

    Article  PubMed  CAS  Google Scholar 

  • Petersen EE, Doerr HW, Gross G, Petzoldt D, Weissenbacher ER, Wutzler P (1999): Der Herpes genitalis. Dtsch Ärztebl 96: A2358-A2364.

    Google Scholar 

  • Post B, Jänner M (1971): Zur Indikation der Gerbstofftherapie in der Dermatologie. Klinische Erfahrungen mit Tannosynt. Ther Ggw 110: 1477–1494.

    PubMed  CAS  Google Scholar 

  • Qureshi AA, Fischer MA (2006): Topical calcineurin inhibitors for atopic dermatitis - Balancing clinical benefit and possible risks. Arch Dermatol 142: 633–637.

    Article  PubMed  Google Scholar 

  • Raborn GW, McGaw WT, Grace M, Eng P, Percy J, Samuels S (1989): Herpes labialis treatment with acyclovir 5% modified aqueous cream: A double-blind, randomized trial. Oral Surg. Oral Med Oral Pathol Oral Radiol Endod 67: 676–679.

    Article  CAS  Google Scholar 

  • Rahimi H, Mara T, Costella J, Speechley M, Bohay R (2012): Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 618–627.

    Article  PubMed  Google Scholar 

  • Ramos-e-Silva M, Oliveira Lima CM, Casz Schechtman R, Moritz Trope B, Carneiro S (2012): Systemic mycoses in immunodepressed patients (AIDS) Clin Dermatol 30: 616–627.

    Article  PubMed  Google Scholar 

  • Rathi SK, D’Souza P (2012): Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol 57:251-259.

    Article  PubMed  Google Scholar 

  • Ring J, Fröhlich HH (1985): Wirkstoffe in der dermatologischen Therapie, 2. Aufl, Springer- Verlag, Berlin Heidelberg.

    Book  Google Scholar 

  • Rotta I, Sanchez A, Gonçalves PR, Otuki MF, Correr CJ (2012): Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. Br J Dermatol 166: 927–933.

    Article  PubMed  CAS  Google Scholar 

  • Ruzicka T (2006): Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. Int J Clin Pract 60: 85–92.

    Article  PubMed  CAS  Google Scholar 

  • Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Holló P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J (2008): Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 158: 808–817.

    Article  PubMed  CAS  Google Scholar 

  • Sapijaszko MJA (2005): Imiquimod 5% cream (Aldara®) in the treatment of basal cell carcinoma. Skin Ther Lett 10: 2–5.

    CAS  Google Scholar 

  • Schäfer-Korting M, Schmid MH, Korting HC (1996): Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375–385.

    Article  PubMed  Google Scholar 

  • Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010): Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39–49.

    Article  PubMed  CAS  Google Scholar 

  • Schneider LA, Hinrichs R, Scharfetter-Kochanek K (2007): Indikationen zur UVB-Phototherapie. Dtsch Med Wochenschr 132: 888–891.

    Article  PubMed  CAS  Google Scholar 

  • Schöfer H, Simonsen L (2010): Fusidic acid in dermatology: an updated review. Eur J Dermatol 20: 6–15.

    PubMed  Google Scholar 

  • Schülke & Mayr GmbH (2011): Octenisept® - Ödematöse Schwellungen und Gewebeschädigungen nach Wundspülungen unter Druck - Warnung vor nicht bestimmungsgemäßem Gebrauch Rote Hand Brief 21. Januar 2011, www.akdae.de/Arzneimittelsicherheit/RHB/20110127.pdf.

  • Schulze-Dirks A, Frosch PJ (1988): Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377.

    PubMed  CAS  Google Scholar 

  • Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR (2011): Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-? inhibitors: The Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol. 2011 Jul 11. [Epub ahead of print].

    Google Scholar 

  • Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D, International Wound Bed Preparation Advisory Board, Canadian Chronic Wound Advisory Board (2003): Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 49: 23–51.

    Google Scholar 

  • Sigurgeirsson B, Elewski BE, Rich PA, Opper C, Cai B, Nyirady J, Bakshi R (2006): Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomaized, double-blind comparison. J Dermatol Treatm 17: 38–44.

    Article  CAS  Google Scholar 

  • Singal A, Khanna D (2011): Onychomycosis: Diagnosis and management. Indian J Dermatol Venereol Leprol 77: 659–672.

    Article  PubMed  Google Scholar 

  • Smith RG (2008): Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage 54: 16–34.

    PubMed  Google Scholar 

  • Solares CA, Batra PS, Hall GS, Citardi MJ (2006): Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27: 161–165.

    Article  PubMed  CAS  Google Scholar 

  • Spruance SI, Kriesel JD (2002): Treatment of herpes simplex labialis. Herpes 9: 64–69.

    PubMed  Google Scholar 

  • Stille W, Brodt HR, Groll AH, Just-Nübling G (2005): Antibiotika-Therapie. Klinik und Praxis der antiinfektiösen Behandlung, 11. Auflage. Schattauer, Stuttgart-New York.

    Google Scholar 

  • Strömberg HE, Ågren MS (1984): Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 111: 461–468.

    Article  PubMed  Google Scholar 

  • Subissi A, Monti D, Togni G, Mailland F (2010): Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70: 2133–2152.

    Article  PubMed  Google Scholar 

  • Sunderkötter C, Herrmann M, Jappe U (2006): Antimikrobielle Therapie in der Dermatologie. J Dtsch Dermatol Ges 4: 10–26.

    Article  PubMed  Google Scholar 

  • Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerdén B, Bergman U, Jokinen J (2010): Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. Br Med J 341: c5812.

    Article  Google Scholar 

  • Sweetser MT, Dawson KT, Bozic C (2013): Manufacturer’s response to case reports of PML. N Engl J Med 368:1659–161.

    Article  PubMed  CAS  Google Scholar 

  • Tadicherla S, Ross K, Shenefelt PD, Fenske NA (2009): Topical corticosteroids in dermatology. J Drugs Dermatol 8: 1093–1105.

    PubMed  Google Scholar 

  • Tennis P, Gelfand JM, Rothman KJ (2011): Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165: 465–473.

    Article  PubMed  CAS  Google Scholar 

  • Thaçi D, Schöfer H (2005): Topische Antibiotika zur Therapie von Hautinfektionen. Hautarzt 56: 381–396.

    Article  PubMed  Google Scholar 

  • Thielitz A, AbdeL-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H (2010): Topische Retinoide bei Akne - eine evidenzbasierte Übersicht. J Dtsch Dermatol Ges 8 (Suppl 1): S15–23.

    PubMed  Google Scholar 

  • Udompataikul M, Limpa-o-vart D (2012): Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study. J Drugs Dermatol11: 366–374.

    PubMed  CAS  Google Scholar 

  • Uter W, Geier J, Fuchs T (2000): Contact allergy to polidocanol, 1992 to 1999. J All Clin Immunol 106: 1203–1204.

    Article  CAS  Google Scholar 

  • van de Kerkhof PC, Kragballe K, Segaert S, Lebwohl M; International Psoriasis Council (2011): Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol 25: 1130–139.

    Google Scholar 

  • van Oosten BW, Killestein J, Barkhof F, Polman CH, Wattjes MP (2013): PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med 368:1658–1659.

    Article  PubMed  CAS  Google Scholar 

  • van Steensel MAM (2007): Emerging drugs for ichthyosis. Expert Opin Emerg Drugs 12: 647–656.

    Article  PubMed  Google Scholar 

  • van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S (2007): Systematic review of rosacea treatments. J Am Acad Dermatol 56: 107–1015.

    Article  PubMed  Google Scholar 

  • von Krogh G (1978): Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study. Acta Derm Venereol 58: 163–168.

    Google Scholar 

  • von Krogh G, Longstaff E (2001): Podophyllin office therapy against condyloma should be abandoned. Sex Transm Inf 77: 409–412.

    Article  Google Scholar 

  • Walluf-Blume D (1991): Aufbereitung und Nachzulassung von OTC-Arzneimitteln in den USA 1990. Pharm Ind 53: 152–158.

    Google Scholar 

  • Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W (2006): Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai 89: 1654–1658.

    PubMed  Google Scholar 

  • Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA (2005): Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled study. J Am Acad Dermatol 53: 578–584.

    Article  PubMed  Google Scholar 

  • Wickline MM (2004): Prevention and treatment of acute radiation dermatitis: a literature review. Oncol Nurs Forum 31: 237–247.

    Article  PubMed  Google Scholar 

  • Wilkinson JD (1998): Fusidic acid in dermatology. Br J Dermatol 139 (Suppl 53): 37–40.

    Article  PubMed  CAS  Google Scholar 

  • Williams H (2002): New treatments for topic dermatitis. Brit Med J 324: 1533–1534.

    Article  PubMed  Google Scholar 

  • Williams HC, Dellavalle RP, Garner S (2012): Acne vulgaris. Lancet 379: 361–372.

    Article  PubMed  Google Scholar 

  • Wohlrab J (2006): Basistherapie der Psoriasis vulgaris. Hautarzt 57: 661–665.

    Article  PubMed  CAS  Google Scholar 

  • Wolff HH, Kieser M (2007): Hamamelis in children with skin disorders and skin injuries: results of an observational study. Eur J Pediatr 166: 943–948.

    Article  PubMed  Google Scholar 

  • Worret WI, Fluhr JW (2006): Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges 4: 293–300.

    Article  PubMed  Google Scholar 

  • Wright JB, Lam K, Burrell RE (1998): Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am J Infect Control 26: 572–577.

    Article  PubMed  CAS  Google Scholar 

  • Yan J, Chen SL, Wang HN, Wu TX (2006): Meta-analysis of 5% imiquimod amd 0,5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 213: 218–223.

    Article  PubMed  CAS  Google Scholar 

  • Yates JE, Phifer JB, Flake D (2009): Clinical inquiries. Do nonmedicated topicals relieve childhood eczema? J Fam Pract 58: 280–281.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie, Universität zu Köln, Köln, Gleueler Straße 24, 50924

    Prof. Dr. rer. nat. Uwe Fricke

Authors
  1. Prof. Dr. rer. nat. Uwe Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. AOK NORDWEST Die Gesundheitskasse, Edisonstraße 70, 24145, Kiel

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin, Heidelberg

About this chapter

Cite this chapter

Fricke, U. (2013). Dermatika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2013. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37124-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37124-0_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37123-3

  • Online ISBN: 978-3-642-37124-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation